Lack of evidence that beta blocker use reduces knee pain, areas of joint pain, or analgesic use among individuals with symptomatic knee osteoarthritis
Year: 2019
Type: article
Source: Osteoarthritis and Cartilage
Institutions: University of Arizona, University of Florida
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funders: Foundation for the National Institutes of Health, U.S. Department of Health and Human Services, Pfizer, GlaxoSmithKline, Novartis Pharmaceuticals Corporation, National Institutes of Health, EMD Serono, National Heart, Lung, and Blood Institute, National Institute of Arthritis and Musculoskeletal and Skin Diseases
Awards: G1158108047, G166592988, Clinical Centers for the Osteoarthritis Initiative, G3049869442, G409491633, Data Coordinating Center for the Osteoarthritis Initiative, G482432850, Clinical Centers for the Osteoarthritis Initiative, G5672476635, G604760239, G659721583, G724008290, Clinical Centers for the Osteoarthritis Initiative^Rhode Island, Clinical Centers for the Osteoarthritis Initiative, G897039181
OpenAlex ID: W2973081069
